TW202143959A - 一種非布司他片 - Google Patents

一種非布司他片 Download PDF

Info

Publication number
TW202143959A
TW202143959A TW110111923A TW110111923A TW202143959A TW 202143959 A TW202143959 A TW 202143959A TW 110111923 A TW110111923 A TW 110111923A TW 110111923 A TW110111923 A TW 110111923A TW 202143959 A TW202143959 A TW 202143959A
Authority
TW
Taiwan
Prior art keywords
febuxostat
tablet
coating layer
cellulose
core
Prior art date
Application number
TW110111923A
Other languages
English (en)
Chinese (zh)
Inventor
馬愛明
王捷
潘凱
曹笑立
陳愛玲
潘彩雲
Original Assignee
大陸商江蘇恆瑞醫藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商江蘇恆瑞醫藥股份有限公司 filed Critical 大陸商江蘇恆瑞醫藥股份有限公司
Publication of TW202143959A publication Critical patent/TW202143959A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
TW110111923A 2020-03-31 2021-03-31 一種非布司他片 TW202143959A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010244014 2020-03-31
CN202010244014.3 2020-03-31

Publications (1)

Publication Number Publication Date
TW202143959A true TW202143959A (zh) 2021-12-01

Family

ID=77927773

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110111923A TW202143959A (zh) 2020-03-31 2021-03-31 一種非布司他片

Country Status (3)

Country Link
CN (1) CN115297848A (fr)
TW (1) TW202143959A (fr)
WO (1) WO2021197376A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115770226B (zh) * 2022-10-31 2024-06-25 修正药业集团股份有限公司 一种非布司他片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071060B2 (en) * 2005-07-08 2018-09-11 Bioventures, Llc Asymmetrically coated table
CN107530289A (zh) * 2015-02-27 2018-01-02 扣带回治疗学有限公司 三脉冲释放兴奋剂制剂
CN113476421B (zh) * 2017-12-29 2023-04-07 江苏恒瑞医药股份有限公司 一种非布司他的控释组合物及其制备方法
CN109010320B (zh) * 2018-09-18 2021-09-14 浙江汇能生物股份有限公司 一种双释型聚卡波非钙颗粒剂及制备方法和畜禽中的应用
CN110251475B (zh) * 2019-07-25 2021-07-16 沈阳信康药物研究有限公司 一种帕利哌酮片剂及其制备方法

Also Published As

Publication number Publication date
WO2021197376A1 (fr) 2021-10-07
CN115297848A (zh) 2022-11-04

Similar Documents

Publication Publication Date Title
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
RU2376988C2 (ru) Фармацевтические композиции замедленного высвобождения, содержащие аплиндор и его производные
US20170231927A1 (en) Pharmaceutical compositions of memantine
JP2001507359A (ja) 徐放性シサプリドミニ錠剤製剤
CN113476421B (zh) 一种非布司他的控释组合物及其制备方法
US20070243249A1 (en) Novel formulation of pyridoxal-5'-phosphate and method of preparation
US20120121702A1 (en) Controlled Release Azithromycin Solid Dosage Forms
CN112472679A (zh) 双释放片及其制备方法
KR20180097623A (ko) 아프레밀라스트 서방형 제제
WO2021197376A1 (fr) Comprimé de fébuxostat
WO2004096182A1 (fr) Comprimes matriciels a liberation prolongee de carvedilol
WO2007080776A1 (fr) Preparation a liberation prolongee et son procede de production
EP2594269A1 (fr) Comprimé nucléé à libération contrôlée
KR101925590B1 (ko) 개선된 생체이용률을 갖는 페노피브릭산 제제
US20040146556A1 (en) Oral extended release tablets and methods of making and using the same
EP2392318A1 (fr) Composition pharmaceutique à libération prolongée du losartan
CN112057429B (zh) 雷西纳德控释药物组合物
EP3796908B1 (fr) Formulations de propivérine à libération contrôlée
US20150224056A1 (en) Pharmaceutical compositions of ibuprofen and famotidine
US20090068260A1 (en) Beta-1-selective adrenoceptor blocking agent compositions and methods for their preparation
CN115887402A (zh) 一种非布司他片
US20080206338A1 (en) Controlled release formulations of an alpha-adrenergic receptor antagonist
WO2024055984A1 (fr) Composition de nébivolol et d'amlodipine, procédé de préparation s'y rapportant et utilisation associée
KR20240111158A (ko) 레바미피드 또는 이의 약학적으로 허용 가능한 염을 유효 성분으로 포함하는 서방성 다층정제 및 이의 제조 방법
US20130236538A1 (en) Pharmaceutical compositions of ibuprofen and famotidine